• Development of Novel Nerve Repair & Regeneration Products
• Expanding Product Portfolio with 4 product ranges expected by year end
• Strong Sales & Distribution Presence in the US with plans for global expansion

ReNerve is developing a comprehensive portfolio of products for the nerve repair and regeneration markets and related surgical procedures, with clearly defined commercial demand. The company is expanding its product portfolio, with 4 product ranges expected on the market by the end of the year (CY'25), and more in development and research. ReNerve has established logistics, warehouse and invoicing infrastructure with a strong focus on building a sales distribution network for all products in the US, and is also experiencing successful ongoing expansion within the first year of ASX listing into ex-US markets in Asia, India, the Middle East, and the Americas. The company's products have shown improved patient outcomes for post-surgical measures of pain and surgery satisfaction, as well as proven ease of use for surgeons. The global nerve repair biomaterials market is forecast to grow by over 17% per annum, estimated to be worth over US$6.19Bn by 2031, with significant opportunities for ReNerve's diverse product portfolio.

ReNerve expects to have 4 product ranges in the market by the end of 2025, with additional products currently under development. The company is targeting market release of its Nerve Cuff product in the 4th quarter of CY'25, the Bionic Nerve product in Q2 CY27, and the Nerve Conduit product in Q3 CY28. The total addressable market for these products is estimated to be over $400 million in 2023, growing to over $6 billion by 2030.

ReNerve is focused on continued market engagement, with 3 new product ranges expected to be introduced into the US market in CY'25. The company is also working with distributors to secure additional approvals in India and other Asian countries. ReNerve is taking a targeted-direct sales approach in the US, supporting its 21 distributors to drive sales of its NervAlign Nerve Cuff and grow the company's revenue.